Cargando…
Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease
From the 33,000 men in the U.S. who die from prostate cancer each year, the majority of these patients exhibit metastatic disease with bone being the most common site of metastasis. Prostate cancer bone metastases are commonly blastic, exhibiting new growth of unhealthy sclerotic bone, which can cau...
Autores principales: | Straign, Desiree M., Ihle, Claire L., Provera, Meredith D., Owens, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702552/ https://www.ncbi.nlm.nih.gov/pubmed/34956082 http://dx.doi.org/10.3389/fendo.2021.769316 |
Ejemplares similares
-
Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers
por: Provera, Meredith D., et al.
Publicado: (2022) -
Loss of Myeloid BMPR1a Alters Differentiation and Reduces Mouse Prostate Cancer Growth
por: Ihle, Claire L., et al.
Publicado: (2020) -
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
por: Ihle, Claire L., et al.
Publicado: (2019) -
Chordin-Like 1 Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells Through Enhancing BMP4-SMAD Pathway
por: Liu, Tao, et al.
Publicado: (2019) -
Adipocyte-Cancer Cell Interactions in the Bone Microenvironment
por: Otley, Meredith O. C., et al.
Publicado: (2022)